radiation retinopathy
Showing 1 - 10 of 10
Radiation Retinopathy, Visual Impairment Trial (Faricimab, fluocinolone acetonide)
Not yet recruiting
- Radiation Retinopathy
- Visual Impairment
- Faricimab
- fluocinolone acetonide
- (no location specified)
Apr 25, 2023
Radiation Retinopathy Trial in Cleveland (Fluocinolone Acetonide (FA) implant)
Withdrawn
- Radiation Retinopathy
- Fluocinolone Acetonide (FA) implant
-
Cleveland, OhioCole Eye Instiute
Aug 2, 2021
Radiation Retinopathy Trial in United States (0.5 mg ranibizumab, Targeted Retinal Photocoagulation (TRP))
Completed
- Radiation Retinopathy
- 0.5 mg ranibizumab
- Targeted Retinal Photocoagulation (TRP)
-
Dallas, Texas
- +3 more
Mar 24, 2021
Macular Edema, Radiation Retinopathy, Branch Retinal Vein Occlusion Trial in Palo Alto (Episcleral Dexamethasone)
Unknown status
- Macular Edema
- +6 more
- Episcleral Dexamethasone
-
Palo Alto, CaliforniaStanford Medicine Ophthalmology
Oct 7, 2019
Macular Edema, Cystoid Macular Edema, Uveal Melanoma Trial in Philadelphia (Ozurdex, Bevacizumab)
Terminated
- Macular Edema
- +4 more
-
Philadelphia, PennsylvaniaOcular Oncology Service, Wills Eye Institute
Aug 29, 2019
Radiation Retinopathy, Macular Edema Trial in Saint Louis, Houston (Aflibercept every 2 months, Aflibercept monthly)
Completed
- Radiation Retinopathy
- Macular Edema
- Aflibercept every 2 months
- Aflibercept monthly
-
Saint Louis, Missouri
- +1 more
Apr 24, 2019
Radiation Retinopathy Trial in New York (ranibizumab 2.0 mg)
Completed
- Radiation Retinopathy
- ranibizumab 2.0 mg
-
New York, New YorkThe New York Eye Cancer Center
Sep 30, 2014
Radiation Retinopathy, Choroidal Melanoma Trial in New York (Ranibizumab, ranibizumab)
Completed
- Radiation Retinopathy
- Choroidal Melanoma
-
New York, New YorkThe New York Eye Cancer Center
Apr 25, 2012
Uveal Melanoma, Radiation Retinopathy, Radiation Maculopathy Trial in Philadelphia (Ranibizumab)
Unknown status
- Uveal Melanoma
- +2 more
-
Philadelphia, PennsylvaniaWills Eye Institute
Oct 5, 2007